Periprocedural Antithrombotic Treatment in Complex Percutaneous Coronary Intervention

Area of Science:

• Interventional Cardiology
• Cardiovascular Medicine

Background:

• Management of complex lesions during percutaneous coronary intervention (PCI) is a significant concern in interventional cardiology.
• Increased risk of ischemic events in patients with complex lesions undergoing PCI necessitates optimized antithrombotic strategies.

Purpose of the Study:

• To evaluate optimal periprocedural antithrombotic treatment strategies for complex PCI.
• To assess the safety and efficacy of current anticoagulation recommendations.
• To investigate the role of potent P2Y12 inhibitors in specific patient subgroups.

Main Methods:

• Review of current evidence on antithrombotic therapy in complex PCI.
• Analysis of periprocedural (pre-PCI, during-PCI, post-PCI) treatment approaches.
• Focus on patient subgroups including non-ST segment elevation myocardial infarction and stable coronary artery disease.

Main Results:

• Current antithrombotic recommendations require further evidence for safety and efficacy in complex PCI.
• Potential benefits of potent P2Y12 inhibitors in specific patient cohorts undergoing complex PCI warrant investigation.
• Need for data on the impact of potent P2Y12 inhibitors in stable coronary artery disease patients with complex lesions.

Conclusions:

• Evidence is needed to guide optimal antithrombotic strategies for complex PCI.
• Refined antithrombotic protocols can improve the balance between safety and efficacy.
• Further research will aid clinicians in managing challenging PCI cases effectively.